Brief: Ginkgo Bio, SaponiQx Awarded MCDC Contract To Discover And Manufacture Next-Generation Vaccine Adjuvants

Ginkgo Bioworks Holdings

15/02/2024 12:46

Feb 15 (Reuters) - Ginkgo Bioworks Holdings Inc  DNA.N :
    * GINKGO BIOWORKS AND SAPONIQX AWARDED MCDC CONTRACT TO
DISCOVER
AND MANUFACTURE NEXT-GENERATION VACCINE ADJUVANTS USING
GENERATIVE MOLECULAR DESIGN
    * GINKGO BIOWORKS - 5-YEAR CONTRACT TOTALING UP TO $31
MILLION
INCLUDING PROGRAM OPTIONS

Source text for Eikon:  ID:nPn6wG2BKa 
Further company coverage:  DNA.N 

 ((Reuters.Briefs@thomsonreuters.com;))